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Background
Macrophages infiltrate adipose tissue at the onset of
weight gain and directly contribute to adipose inflamma-
tion, insulin resistance, and obesity [1]. The type of fuel
substrate utilized by macrophages is central to the forma-
tion of obesity, a global epidemic [2]. Our goal is to under-
stand the role of macrophage glucose metabolism in the
promotion of inflammation and insulin resistance during
high fat diet-induced obesity. We hypothesize that macro-
phages with blunted or elevated glucose metabolism will
display limited or exaggerated immune responses, and
modulate susceptibility to insulin resistance and obesity,
respectively.
Materials and methods
GLUT1 is the glucose transporter expressed by macro-
phages [3]. We manipulated macrophage glucose metabo-
lism using GLUT1 over-expression and deletion
techniques in vitro, ex vivo,a n din vivo. In vitro studies
involved over-expression of GLUT1 in RAW264.7 cells. A
high fat diet-induced obesity model involving a novel
macrophage-specific Glut1 knockout mouse (Glut1MF
-/-)
was used to assess total body weight, glucose tolerance, tis-
sue histological alterations, and gene expression changes
resulting from Glut1 deletion. Bone marrow-derived
macrophages (BMDMs), isolated from Glut1MF
-/-mice
fed a control diet, were used for measures of polarization,
and glucose uptake and metabolism.
Results
GLUT1 over-expression resulted in elevated glucose
uptake and metabolism, as well as a hyper-inflammatory
state characterized by elevated secretion of MCP-1 and
PAI-1, all of which could be blunted with a pharmacologic
inhibitor of glycolysis. Preliminary data suggests that
Glut1MF
-/- mice fed a high fat diet were resistant to obe-
sity, remained normoglycemic and demonstrated blunted
inflammation in liver and adipose. Glut1MF
-/- BMDMs
were viable, but metabolized less glucose at baseline and
after LPS stimulation.
Conclusions
The capacity to use glucose as a fuel is correlated to the
inflammatory status of macrophages which likely plays an
integral role in the promotion of obesity-related insulin
resistance. Possible mechanisms linking glucose metabo-
lism to inflammation are being investigated. Understand-
ing macrophage glucose metabolism and inflammation
will identify metabolic and/or signaling pathways that will
serve as novel therapeutic targets in the treatment of
diabetes and obesity.
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